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Background: We previously reported that a pool of low molecular weight peptides can be extracted by alkali
treatment of DNA preparations obtained from prokaryotic and eukaryotic cells after intensive deproteinization. This
class of peptides, isolated from wheat bud chromatin, induces growth inhibition, DNA damage, G2 checkpoint
activation and apoptosis in HeLa cells. In this work we studied their mechanism of action by investigating their
ability to interfere with DNA synthesis.
Methods: BrdUrd comet assays were used to detect DNA replication defects during S phase. DNA synthesis, cell
proliferation, cell cycle progression and DNA damage response pathway activation were assessed using
3H-thymidine incorporation, DNA flow cytometry and Western blotting, respectively.
Results: BrdUrd labelling close to DNA strand discontinuities (comet tails) detects the number of active replicons.
This number was significantly higher in treated cells (compared to controls) from entry until mid S phase, but
markedly lower in late S phase, indicating the occurrence of defective DNA synthesis. In mid S phase the treated
cells showed less 3H-thymidine incorporation with respect to the controls, which supports an early arrest of DNA
synthesis. DNA damage response activation was also shown in both p53-defective HeLa cells and p53-proficient
U2OS cells by the detection of the phosphorylated form of H2AX after peptide treatment. These events were
accompanied in both cell lines by an increase in p21 levels and, in U2OS cells, of phospho-p53 (Ser15) levels. At
24 h of recovery after peptide treatment the cell cycle phase distribution was similar to that seen in controls and
CDK1 kinase accumulation was not detected.
Conclusion: The data reported here show that the antiproliferative effect exhibited by these chromatin peptides
results from their ability to induce genomic stress during DNA synthesis. This effect seems to be S-phase specific
since surviving cells are able to progress through their normal cell cycle when the peptide fraction is removed from
the culture medium. It is likely that the subsequent apoptosis is a consequence of the failed attempt of the tumour
cells to repair the DNA damage induced by the peptides.
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Alkali treatment of deproteinized DNA from mamma-
lian and plant cells (calf thymus, bull spermatozoa, trout
testis, wheat germ, pea and wheat bud) dissociates a pool
of peptides of about 1000 Da with strongly related
amino-acid composition. Their affinity for DNA is pH-
dependent and is lower at alkaline pHs [1,2]. We previ-
ously reported that this class of peptides is able to inhibit
RNA transcription in cells and in vitro reconstituted sys-
tems and to decrease cell growth of several tumour cell
lines [3,4]. The removal of this fraction by alkaline buffer
from the DNA of normal cells increases the DNA tem-
plate capacity, but this effect is practically absent for the
DNA of several cancer cell lines [5]. Accordingly, their
concentration in the chromatin of cancer cells is lower
than that present in the chromatin of the corresponding
normal cells [6] so it is likely that they exert a role in con-
trolling the mechanism of cell transformation. Studies
aimed at investigating their effects on cell proliferation
showed that this pool of peptides induced accumulation
of cells in G2 phase, DNA damage and apoptosis in HeLa
cells. We also reported that they activate the G2 check-
point pathway, the regulatory mechanism that prevents
entry of the cells into mitosis in response to defective
DNA replication. The growth rate inhibition is obtained
when the cells are treated during S phase only [7]. We
therefore hypothesize that the antiproliferative effect
exhibited by these chromatin peptides results from their
action during DNA synthesis. In this study we wanted to
investigate the effect of these peptides on the progression
of DNA synthesis and evaluate the cellular response to the
induced DNA damage.
Results
Cell cycle arrest and apoptosis were induced in HeLa
cells after incubation with a pool of peptides extracted
from wheat bud chromatin [7]. A mechanism of action
was proposed in which the inhibition of cell growth re-
sults from their ability to affect DNA replication. In
order to provide a more detailed picture of their action
on this process, we performed the BrdUrd Comet assay
in synchronized HeLa cell cultures during the DNA syn-
thesis. S phase cells were obtained by the double thymi-
dine block that arrests the cells at the G1/S boundary.
The removal of thymidine by replacement with normal
medium induces the onset of S phase. DNA synthesis
was analyzed by determination of 3H thymidine incorp-
oration into DNA at 1 hour intervals. The time course
of incorporation indicates that 3H thymidine uptake initiates
shortly after the removal of the thymidine block, reaches the
maximum after 6 hours and drops at 8 hours. This pattern
demonstrates the occurrence of synchronization since cells
not subjected to the thymidine block show a constant in-
creasing rate of 3H thymidine incorporation (data notshown). Immediately after the removal of the thymidine
block, the cells were incubated with the peptide pool for
2.5, 4, 6 and 7 hours, while replicating DNA was labelled
by adding the thymidine analogue BrdUrd to the culture
medium. The cells were then collected and subjected to
the comet assay. The label incorporation was detected,
following electrophoresis of the cells, by immunological
assay. Figure 1 shows the localization of such label at dif-
ferent time points during DNA synthesis and the quantifi-
cation of the DNA fragmentation (PI staining) and
BrdUrd labelling (FITC staining) within the comet tails. In
the control cells, at the beginning of the DNA synthesis
(2.5 hours from the removal of thymidine block), little
DNA fragmentation was detected. After 4 hours from the
onset of the DNA synthesis, DNA fragmentation was
detected and the BrdUrd label was localized close to the
strand discontinuities, constituting the comet tails. In late
DNA synthesis, 6 and 7 hours from the onset of the DNA
replication, the level of the DNA strand breaks and
BrdUrd incorporation in the tails decreased. In the treated
cells, from the beginning (2.5 time point) till mid S phase,
the levels of DNA fragmentation and tail labelling were
significantly higher than in the controls. They reached the
maximum value after 4 hours from the onset of the S
phase, remained roughly the same at 6 hours and sharply
decreased at the 7-hour time point. We determined the
DNA synthesis activity at 5 and 6 hours from the begin-
ning of the S phase by pulse labelling the cells with 3H
thymidine for 30 min. The radioactivity incorporation per
cell was lower in the treated cells respective to the control
cells (Figure 1d). These data support our hypothesis of an
action of this pool of peptides in the DNA replication
process.
In response to DNA replication stress, checkpoint pro-
teins are activated to trigger the DNA repair machinery.
A critical component of the signaling pathway is repre-
sented by the histone H2AX that, in its phosphorylated
form γH2AX, specifically attracts proteins leading to the
formation of nuclear DNA repair foci [8]. In order to in-
vestigate the induction of the DNA repair pathway fol-
lowing replication stress, we checked the expression of
γH2AX in peptide treated cells. We tested two cell lines,
HeLa and U2OS, that differ in their expression of the
p53 protein. While in HeLa p53 is inactivated by the E6
protein encoded by the HPV genes [9], in U2OS it can
be induced in the mediation of the cellular response to
genotoxic stress. We first checked whether the peptide
pool exerted antiproliferative effects also in U2OS cells
with functional p53. We obtained (Figure 2) a level of
growth inhibition in treated U2OS cultures comparable to
that obtained for HeLa cells. In Figure 3 we show that the
peptide treatment increases the percentage of γH2AX
positive cells and the average number of γH2AX foci per
cell in both cell lines. The involvement of p53 has been
Figure 1 Analysis of DNA synthesis in S phase synchronized HeLa cells. Left panel: images of the BrdUrd Comet assay performed at 2.5, 4,
6 and 7 hours from the beginning of DNA synthesis. The pictures, obtained by fluorescence microscopy show identical comet fields with FITC
(green) and propidium iodide staining (red). C: control cells. T: treated cells. Right panel: Quantification of DNA synthesis at different time points
from the beginning of S phase. (a): representative image of BrdUrd-Comet assay (INGR ×150, FITC staining), the percentage of tail DNA shared
uniform distribution among the various comet formations. Tail moment measured following FITC (b) and PI (c) stainings, respectively. Controls
(triangles); treated (squares). Results shown are the mean ± SE of 25 cells. (d): Thymidine incorporation per cell at 5 and 6 hours from the
beginning of S phase. Control cells (black), treated cells (grey). The error bars show the standard deviation obtained from three independent
experiments. Student’s test. *p < 0.05 **p < 0.01.
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Figure 2 Cell growth inhibition of tumour cell lines induced by the peptide fraction. HeLa (a) and U2OS (b) cells were treated with 1 μg/ml
(white) and 2 μg/ml (black) of peptide pool for 1, 2 and 4 days. Gray bars represent untreated controls. Error bars show the standard deviation
obtained from three independent experiments. Student’s test. *p < 0.05 **p < 0.01.
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sion of phospho p53 (Ser-15) which is induced during the
cellular response to DNA damage. The exposition of
U2OS cells for 4 days to the peptide pool results in an in-
crease of 4.5 times the control level of the expression of
active p53. In agreement with Western Blot analysis, im-
munofluorescence results revealed a higher percentage of
phospho-p53 (Ser-15) positive cells in the treated culture
with a higher average level of fluorescence intensity per
cell with respect to the control cells (Figure 4). Several
small molecules with the ability to reactivate mutant p53
have been reported [10]. We therefore checked the possi-
bility that in HeLa cells the treatment could interfere with
the p53 degradation to recover its function, but no expres-
sion of phospho p53 was detected in this cell line (data
not shown).
We also investigated the expression level of the p21
protein, an inhibitor of CDK-cyclin complexes, since it
has been reported to arrest cell cycle progression in re-
sponse to DNA damage. Western Blot analysis showed
that the level of p21 expression in treated Hela and
U2OS cells is higher compared to the controls (Figure 5).This suggests the involvement of p21 protein in the
pathway adopted by the cells to induce G2 phase block
that occurs after a defective DNA replication in the cells
treated with the peptide pool.
We have previously reported that cell growth inhib-
ition is obtained when synchronized cells are treated
during S phase only [7]. In order to assess the selectivity
of the peptide action on the replication process, we evalu-
ated the ability of the surviving cells to undergo a normal
cell cycle progression after the removal of the peptide frac-
tion from the culture medium. Unsynchronized HeLa cells
were exposed to the peptide pool for 12 hours, then the
pool was removed from the medium and cells were grown
in normal medium for 24 hours. Cell cycle analysis and
CDK1 expression level were measured at each time point.
12 hours of treatment induced G2 arrest and an accumu-
lation of CDK1 kinase in the G2 cells. After 24 hours of
recovery the cell distribution in the different phases of the
cell cycle was the same as in the untreated cells. As shown
in Figure 6, G2 arrest and CDK1 kinase accumulation
were not detected. Taken together, these data demonstrate
that the peptide pool exerts a selective action on S phase
Figure 3 Immunofluorescence of U2OS and HeLa cells treated with the peptide pool (2 μg/ml) for 24 and 96 hours. Top panel: confocal
microscope images of phospho-foci stained with γH2AX antibody (green) and DAPI (blue). Lower panel: percentage of γH2AX positive cells, and
average number of γH2AX foci per cell as scored from 100 cells. Error bars show the standard deviation obtained from four independent
experiments. Student’s test. *p < 0.05 **p < 0.01.
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remaining cell population, unaffected, can continue cell
cycle progression.
Discussion
A class of DNA binding peptides is reported to be able
to control HeLa cell proliferation by causing arrest of
cell cycle progression in G2 phase and apoptosis. The in-
hibition of cell growth is obtained when synchronized
cells are treated during S phase only and is accompanied
by DNA damage, increase in the expression of the active
Chk1 kinase and accumulation of the inactive CDK1
kinase in G2 cells. These findings indicate that the suc-
cess of this pool of peptides in arresting the tumour cell
cycle could result from their ability to affect DNA repli-
cation and as a consequence, to activate the checkpoint
pathway that prevents mitosis of cells with damaged
DNA. In order to provide more evidence supporting this
mechanism, we wanted to assess the defective DNA rep-
licative integrity and the possible induction of DNA re-
pair processes in cells exposed to this class of peptides
in the present study.
We performed the BrdUrd-Comet assay on S phase-
synchronized HeLa cells at various time points from the
onset of DNA synthesis. In the control cells, the DNA
replicating label is initially detected within the tails ofthe comets, close to the DNA fragments that are gener-
ated at the leading and lagging strand growth points. Its
amount within the strand discontinuities provides evi-
dence of the number of the initiation sites of DNA synthe-
sis [11]. They increased until mid S phase and decreased
in the second half of DNA synthesis. After treatment of
the cells with the peptide pool, the numbers of active sites
present until mid S phase were higher respective to the
control cells, while in late S phase the numbers sharply
decreased and were lower than those reported for control
cells.
It is now accepted that in eukaryotic cells, replication
origins are activated at different times through S phase
following a stochastic program. The time dependent rate
of initiation (number of initiation per time unit per unit
of length of unreplicated DNA), i(t), increases until mid
S phase and sharply decreases before the end. The in-
creasing number of active replication sites during a nor-
mal DNA synthesis, as S phase progresses, is due to an
increased efficiency of origin firing, while their decrease
is a consequence of the mechanism of self limiting ac-
tion of the fork density [12]. The behaviour of control
cells in our BrdUrd Comet assay is therefore consistent
with this temporal regulation of origin activation. In
treated HeLa cells the number of active replicons, in
early and mid S phase, is higher than in the controls
Figure 4 Analysis of p53 expression in U2OS cells treated with the peptide pool for 24 and 96 hours. Immunofluorescence of U2OS cells
stained with DAPI (blue) and p53 antibody (red). The percentage of γH2AX positive cells, derived from five different fields, and the average
number of γH2AX foci per cell, as scored from 100 cells, are reported. Lower panel: Western blot analysis image and densitometric quantization
of phospho-p53 level following normalization with tubulin.
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[11] that the BrdUrd Comet method detects strand dis-
continuities in recently replicated domains of DNA
caused during replication and that the arrest of replica-
tive polymerase at DNA lesions prolongs the duration of
these breaks. Therefore it is likely that the peptide treat-
ment induces stalled replication forks and a delay in the
maturation process of DNA, which are responsible for
the reported higher amount of BrdUrd labelling in the
comet tails. Accordingly, despite the higher number of
active replicons in the treated cells respective to the con-
trols, the amount of 3H thymidine incorporation per cell
in mid S phase, was lower in agreement with an arrest
in DNA synthesis. It is likely that such arrest in DNA
maturation is responsible for the sharp decrease in the
number of active replicons reported in treated cells inlate S phase, in agreement with the self limiting mechan-
ism mentioned above.
Alternatively, the observed differences in BrdUrd la-
belling in the comet tail between treated and control
cells could be due to the action of the peptide pool in in-
creasing the efficiency of origin firing. It has been
reported [13] that a higher number of active sites of rep-
lication could be explained by a better availability of
some limiting factor for DNA replication. The drop in
the number of active replicons detected in treated cells
at the end of the S phase, according to the stochastic
model of replication origin activation, is due to the nega-
tive correlation between fork density and origin firing.
Although further experiments are needed to assess the
mechanism of action of the peptide pool, the data
reported in this work demonstrate that the peptide acts
Figure 5 Analysis of p21 expression in Hela and U2OS cell lines. Western Blot analysis was performed in the cells treated for 24 and
96 hours with the peptide fraction. Densitometric quantification of p21 levels were obtained following normalization with tubulin. The molecular
weight standards are shown on the left.
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DNA damage and early arrest of DNA synthesis. Con-
sistent with these findings, we previously obtained G2
checkpoint pathway activation and a shortening of S
phase length after peptide treatment in HeLa cells.
p53 protein plays a central role in the cellular response
to DNA damage [14], therefore we investigated whether
the peptide pool failed to inhibit cell growth in p53 posi-
tive tumour cells. We obtained an antiproliferative effect
in U2OS cells comparable to the one obtained in HeLa
cells where p53 is inactivated, thus showing the possibil-
ity for this class of peptides to affect the proliferation of
tumor cell lines with differing p53 functionalities. We
also found expression of γH2AX in both cell lines
treated with the peptide pool, which demonstrates the
induction of the cellular response to the DNA damage.
In U2OS cells this process involves activation of p53,
which is reflected by the phosphorylation of Ser15, the
consensus site for a series of kinases, such as ATM/
ATR/DNA-PK, activated during the DNA repair path-
way [15]. We also obtained an increase in the expression
of p21 in HeLa and U2OS treated cells, which demon-
strates the involvement of this protein in the cellularactivated response, by its action in arresting cell cycle
progression to allow cells to repair DNA damage [16].
While in U2OS cells p21 induction is a consequence of
p53 activation, in HeLa cells, increase in expression of
p21 is due to a p53-independent mechanism.
Using the same procedure, we have extracted this class
of peptides from the chromatin of different types of
mammalian and plant cells. Their ubiquitous presence is
consistent with their involvement in a conserved mech-
anism such as the control of the DNA synthesis process.
We also showed that this effect is highly selective, since
the cells that survived the treatment are able to recover
their normal cell cycle progression in the absence of the
peptide pool. Therapeutic selectivity and low toxicity are
the major goals in designing novel anticancer drugs. In
this context, peptide based therapies offer some import-
ant advantages over other chemotherapy molecules such
as high affinity and specificity for target molecules, low
toxicity and good bio-availability [17]. Experiments are
in progress to identify the pool sequence(s) responsible
for the reported effects.
Mass spectrometry analysis has allowed identification
of some structures with sequences very similar to those
Figure 6 Flow cytometry analysis of the cells treated with the peptide pool. a: Percentage of cells in G1 (black), S (white) and G2 (grey)
phases after 12 hours of peptide treatment (T) and after 24 hours of recovery (36-hour time point) in fresh medium (T rec.). C and C rec. represent the
corresponding controls. The experiment shown is representative of three independent experiments. b: percentage of cells expressing CDK1cyclinB
complex following 12 hours of treatment and 24 hours of recovery (36-hour time point) in normal medium. Control cell (black), treated cells (grey).
Error bars show the standard deviation obtained from three independent experiments. Student’s test. *p < 0.05 **p < 0.01.
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many transcription factors such as RNA pol.II Sub.215
KD, PML, HPV18E7, Human Myc, Chicken Myb, Hu-
man Rfx, human Ubf1, RNA Pol.Sigma 70 factor [18].
However, unpublished preliminary evidence suggests
that the reported effects on cell growth result from the
action of various sequences or from a complex of differ-
ent molecules. Further studies are needed to improve
HPLC purification and mass spectrometry analysis in
order to identify new molecules belonging to the pool.
Conclusions
We have studied the mechanism of action of a highly-
conserved class of DNA binding peptides with the abilityto inhibit tumor cell growth. We report here that the main
action of these antiproliferative peptides is impairment of
the replicative integrity causing an early arrest of DNA
synthesis. The resulting genomic stress induces the activa-
tion of the checkpoint pathway to allow the cells to repair
the DNA damage. It is likely that the subsequent apoptotic
process is a consequence of the inability of the tumour
cells to repair the DNA damage and re-enter the cell cycle.
It is possible to speculate that tumour cells, characterized
by a high replicative activity and a defective DNA repair
machinary, are the main target for the antiproliferative ef-
fect of our chromatin peptides. Studies directed to this
hypothesis may be helpful in providing a potential
therapeutic approach for the treatment of cancer.
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Purification of peptides
The purification of peptides from wheat bud chromatin
has been performed following the procedure previously de-
scribed [2]. Briefly, the chromatin was purified at slightly
acidic pH and then subjected to alkaline extraction. The
macromolecules were removed by centrifugation after the
treatment with two volumes of methanol, overnight at
4°C. The supernatant was recovered and the peptides were
purified by gel filtration chromatography at Ve/V0 = 2.
Cell culture
Human osteosarcoma U2OS and cervical cancer HeLa
cell lines were obtained from the American Type Cul-
ture Collection (ATCC; www.atcc.org) and tested for
mycoplasm by using Mycoplasma Detection Kit (Roche
Germany). They were grown in 25 cm2 flasks in 5 ml of
Dulbecco’s Modified Eagle Medium with 10% fetal calf
serum, penicillin at 100 units/ml, streptomycin at
100 μg/ml and 2 mM glutamine (Invitrogen Paisley UK)
at 37°C humidified atmosphere of 5% CO2/95% air. The
peptides were added to the culture medium 24 hours
after cell seeding (25,000 cells/ cm2). Cell numbers were
evaluated by direct counting using a hemocytometer,
and cell viability was assessed by trypan blue exclusion.
Cell synchronization was obtained by a double thymidine
block as described by Kozaki et al. [19]. 6 h following
seeding, the cells were exposed to 2 mM thymidine
(Sigma) for 16 h, to normal medium for 8 h and to 2 mM
thymidine for 16 h. The subsequent replacement with
normal medium released the cells at the G1/S boundary.
Cell cycle analysis
The cells were trypsinized and analyzed, as previously de-
scribed [7], for DNA content using a FACSCalibur laser
flow cytometer (Becton Dickinson Immunocytometry Sys-
tems, San Jose, CA). Pulse-processed fluorescence signals
were used to exclude doublets and aggregates from ana-
lyses. Ten thousand events were acquired for each sample.
Percentages of cells in the G1, S, and G2 M phases of the
cell cycle were quantified using WinCycle software (Phoe-
nix Flow Systems, San Diego, CA).
Cdc2 immunofluorescence analysis
Cells (2 × 106) were trypsinized, washed twice with
10 mM phosphate buffer (PBS) and fixed in 90% ethanol.
After washing in PBS the pellet was treated with PBS
plus 0.1% Triton X and resuspended in 100 μl PBS
containing 0.1% Triton X100 plus 3% non-fat dry milk.
The primary antibody (cdc2, Santa Cruz Biotechnology)
was added to a final concentration of 2 μg/ml, and
allowed to incubate on ice for 1 hour. Suspensions were
then washed in PBS containing 0.1% Triton X100. Pellets
were resuspended and incubated with PBS containing0.1% Triton X100, 3% non-fat dry milk, and biotinylated
horse-anti-mouse IgG (1:50 dilution of stock, Vector Labs,
Burlingame, CA) for 30 minutes. Suspensions were then
washed in PBS containing 0.1% Triton X100. Pellets were
resuspended and incubated with PBS containing 0.1% Tri-
ton X100, 3% non-fat dry milk, and streptavidin-FITC
(1:50 dilution of stock, Amersham Biosciences, UK) for
30 minutes. Suspensions were again washed in PBS
containing 0.1% Triton X100, and then resuspended in
5 μg/ml propidium iodide made up in PBS containing
0.1% Triton X100, to stain DNA. Samples were then run
on a FACSCalibur flow cytometer, and correlated analyses
of cell cycle proteins and DNA content (to allow for cell
cycle analysis) were generated.
Incorporation of 3H thymidine into DNA
Synchronized cells were grown at a cell density of 10000/cm2.
At different time points from the removal of the thymidine
block, the cells were incubated with 1 μCi/ml of 3H-
thymidine (Amersham, Buckinghamshire, UK) for 30 min.
Radioactivity incorporation was measured by liquid scin-
tillation counting as previously described [7].
BrdUrd-comet assay
The cells were seeded at a 10000/cm2 cell density and
synchronized by the double thymidine block. Immedi-
ately after their release in S phase, the cells were incu-
bated with the peptide pool and the thymidine analogue
BrdUrd (100 μM/ml) for 2.5, 4, 6 and 7 hours. The cells
were then harvested by trypsinization, washed twice with
PBS and subjected to the alkaline comet assay following
the procedure already described [7]. After electrophor-
esis, the slides were rinsed in neutral buffer (0.4 M
Tris-HCl pH 7.5) and the incorporation of BrdUrd was
immunologically detected according to the procedure
reported by Mc Glyn et al. [11]. Briefly, 25 μl of mouse
monoclonal anti-BrdUrd (10 μg/ml, Sigma) was added
to each slide and allowed to incubate in the dark, at
room temperature, for 1 h.
The primary antibody was removed by three washes with
PBS and one wash with PBS plus 0.1% BSA. Each slide was
then incubated with 25 μl of secondary anti-body (5 μg/ml
sheep anti-mouse IgG, Sigma) for 1 h in the dark at room
temperature and rinsed as before. The DNA was
counterstained with propidium iodide (0.75 μl/ml, Sigma)
and the comet formations were analyzed using the fluor-
escence microscope LEICA DMRB. Tail moment was cal-
culated by analysing 25 cells for each time point.
DNA damage analysis by immunofluorescence staining
Cells (0.03*10^6) were plated on a coverslip in a 12-well
plate, and the peptidepool was added to the culture
medium 24 hours after cell seeding. When indicated at
different time points, cells were washed with Dulbecco’s
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Inc. USA #17-512 F) 3x and fixed with 4% paraformalde-
hyde (Sigma-Aldrich #P6148-500G) in PBS. Cells were
permeabilized using 0.5% Triton X-100 in PBS for 5 min at
RT. The blocking solution used was 5% Bovine Serum Al-
bumin in PBS for 30 min at RT. The slides were incubated
with phospho (γ)-H2AX (Ser 139 Millipore) and phospho-
p53 (Ser15 Cell Signaling) primary antibodies diluted in 5%
BSA in PBS for 1 hour at RT and then with anti-mouse
Cy3 or Alexa 488 (Jackson Laboratory) secondary antibody
in PBS 1% BSA for 45 min. Nuclei were stained with 4,6-
diamidino-2-phenylindole (DAPI Sigma-Aldrich). Stained
slides were mounted with Mowiol and analyzed using an
Olympus microscope equipped with a CCD color camera
(Hamamatsu). Imaging statistics were performed using
ImageJ software (http://rsbweb.nih.gov/ij/). 100 cells/time
point were evaluated for positive/negative staining, the
number of foci/nucleus and signal intensity for both
γH2AX and phospho-p53 proteins using different ImageJ
plugins.
Western blotting
Cells were lysed in Laemmli buffer and samples were
electrophoresed on SDS-polyacrylamide gels. Separated
proteins were transferred onto a nitrocellulose membrane,
which was then incubated with the following antibodies:
p21 (Santa Cruz), phospho-p53 (Ser15) (Cell Signaling) and
β-tubulin (Sigma-Aldrich), each made up in 5% fat-free
milk. Secondary antibodies were peroxidase-conjugated
anti-mouse or anti-rabbit antibodies. Hybridizations
were detected by enhanced chemiluminescence (ECL
GE Healthcare, Amersham Bioscience, Piscataway, NJ,
USA). WB signal quantification was assessed using
ImageJ software.
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